BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 17093247)

  • 41. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
    Staedke SG; Kamya MR; Dorsey G; Gasasira A; Ndeezi G; Charlebois ED; Rosenthal PJ
    Lancet; 2001 Aug; 358(9279):368-74. PubMed ID: 11502317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.
    Dzinjalamala FK; Macheso A; Kublin JG; Taylor TE; Barnes KI; Molyneux ME; Plowe CV; Smith PJ
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3601-6. PubMed ID: 16127028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi.
    Heymann DL; Khoromana CO; Wirima JJ; Campbell CC
    Trans R Soc Trop Med Hyg; 1987; 81(5):722-4. PubMed ID: 3329780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos).
    Mayxay M; Nair S; Sudimack D; Imwong M; Tanomsing N; Pongvongsa T; Phompida S; Phetsouvanh R; White NJ; Anderson TJ; Newton PN
    Am J Trop Med Hyg; 2007 Jul; 77(1):36-43. PubMed ID: 17620628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
    Koram KA; Abuaku B; Duah N; Quashie N
    Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chloroquine-resistant malaria in Malawi.
    Kobbe R; Meyer CG; May J
    N Engl J Med; 2007 Feb; 356(8):868; author reply 869. PubMed ID: 17314350
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
    Nkhoma S; Molyneux M; Ward S
    Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi.
    Verhoeff FH; Brabin BJ; Masache P; Kachale B; Kazembe P; Van der Kaay HJ
    Ann Trop Med Parasitol; 1997 Mar; 91(2):133-40. PubMed ID: 9307654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad.
    Grandesso F; Bachy C; Donam I; Ntambi J; Habimana J; D'Alessandro U; Maikere J; Vanlerberghe V; Kerah CH; Guthmann JP
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):419-26. PubMed ID: 16297419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
    Kerketta AS; Mohapatra SS; Kar SK
    Trop Doct; 2008 Apr; 38(2):82-4. PubMed ID: 18453492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia.
    Warsame M; Abdillahi A; Duale ON; Ismail AN; Hassan AM; Mohamed A; Warsame A
    Bull World Health Organ; 2002; 80(9):704-8. PubMed ID: 12378287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
    Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP
    Malar J; 2007 May; 6():54. PubMed ID: 17477865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire.
    Wolday D; Kibreab T; Bukenya D; Hodes R
    Trans R Soc Trop Med Hyg; 1995; 89(6):654-6. PubMed ID: 8594686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria.
    Legros D; Johnson K; Houpikian P; Makanga M; Kabakyenga JK; Talisuna AO; Taylor WR
    Trans R Soc Trop Med Hyg; 2002; 96(2):199-201. PubMed ID: 12055815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa.
    Bloland PB; Lackritz EM; Kazembe PN; Were JB; Steketee R; Campbell CC
    J Infect Dis; 1993 Apr; 167(4):932-7. PubMed ID: 8450258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area, Venezuela.
    Caraballo A; Rodriguez-Acosta A
    Am J Trop Med Hyg; 1999 Jul; 61(1):120-4. PubMed ID: 10432068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
    Divala TH; Mungwira RG; Mawindo PM; Nyirenda OM; Kanjala M; Ndaferankhande M; Tsirizani LE; Masonga R; Muwalo F; Boudová S; Potter GE; Kennedy J; Goswami J; Wylie BJ; Muehlenbachs A; Ndovie L; Mvula P; Mbilizi Y; Tomoka T; Laufer MK
    Lancet Infect Dis; 2018 Oct; 18(10):1097-1107. PubMed ID: 30195996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria.
    Metzger W; Mordmüller B; Graninger W; Bienzle U; Kremsner PG
    J Antimicrob Chemother; 1995 Oct; 36(4):723-8. PubMed ID: 8591949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.
    Ravenhall M; Benavente ED; Mipando M; Jensen AT; Sutherland CJ; Roper C; Sepúlveda N; Kwiatkowski DP; Montgomery J; Phiri KS; Terlouw A; Craig A; Campino S; Ocholla H; Clark TG
    Malar J; 2016 Nov; 15(1):575. PubMed ID: 27899115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.